Navigate the complexities of cell and gene therapies
BioPharma
Source: biopharmadive.com
Page 4 - Regulatory Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Regulatory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Regulatory Sciences Today - Breaking & Trending Today
FDA Needs Additional Time to Review Sparsentan, Tofersen Applications
The Food and Drug Administration (FDA) has extended the review periods for 2 investigational products: sparsentan and tofersen.
Source: renalandurologynews.com
Biogen Inc.: Biogen Announces FDA's 3-Month Extension of Review Period for the New Drug Application for Tofersen
The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is April 25, 2023 CAMBRIDGE, Mass., Oct. 17, 2022Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration
Source: finanznachrichten.de
BAT's latest research study initiative focus on oral nicotine product Velo
British American Tobacco Plc released Thursday the preliminary results of its latest research study, this time evaluating its oral nicotine product Velo of R.J. Reynolds Tobacco Co.
Source: journalnow.com
TCELS presents Bio Asia Pacific 2022
TCELS, in collaboration with the Asia-Pacific Life Sciences cluster, is organising the Bio Asia Pacific 2022 event, linking researchers and investors in support of medical-health research at the industrial level, as well as improving the quality of life and driving the economy forward.
Source: bangkokpost.com